Research of mechanism and cytotoxicity of newly-developed anticancer drug for gastric cancer using human gastric cells.

Research of mechanism and cytotoxicity of newly-developed anticancer drug for gastric cancer using human gastric cells. - Mechanism and cytotoxicity of newly-developed anticancer drug for gastric cancer.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000022844

Enrollment

100

Registered

2016-06-22

Start date

2016-06-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer

Interventions

Biopsy sampling from gastric cancer. Biopsy sampling from normal gastric mucosa.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) The subjects who agree to participate in the study by written informed consent. 2) A patient who is diagnosed as gastric cancer or normal mucosa.

Exclusion criteria

Exclusion criteria: The subjects who are judged to be inappropriate for this study by doctors conducting the study.

Design outcomes

Primary

Measure	Time frame
Changes of the cancer cell count after the treatment of newly-developed anticancer drug.	—

Countries

Japan

Contacts

Public ContactMasami Ijiri

Asahikawa Medical University Division of Gastroenterology and Hematology/Oncology, Department of Medicine

m-ijiri@asahikawa-med.ac.jp0166-68-2462

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026